Physician profile
Elizabeth L Palavecino
NPI 1790769180
$17,508.26
in general payments reported to CMS, 2019-2025
5 companies · $9,207 in 2025
The $9,207 reported for 2025 was more than what 92% of Medical Microbiology providers received nationally (typical 2025 total: $91.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,682 · 2020: $1,515 · 2023: $4,104 · 2025: $9,207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Travel and Lodging: $1,797 · Food and Beverage: $1,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,359.50 |
| Travel and Lodging | $1,797.49 |
| Food and Beverage | $1,154.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beckman Coulter, INC. | $8,286.46 | 2019-2023 | Microscan |
| Shionogi INC | $4,631.20 | 2025 | Fetroja |
| Biomerieux INC | $4,551.66 | 2025 | Biofire Joint Infection (Ji) Panel |
| Roche Diagnostics Corporation | $38.94 | 2023-2025 | Cintec Plus Cytology, Cobas Pro Ise Analytical Unit |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Palavecino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.